-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Quantifying Menorrhagia and Overview of Non-Surgical Management of Heavy Menstrual Bleeding

Program: Education Program
Session: Hematologic Management of the Patient with Heavy Menstrual Bleeding
Hematology Disease Topics & Pathways:
Education
Saturday, December 7, 2024, 2:00 PM-3:15 PM

Allison P Wheeler, MD/MSCI

University of Washington, Washington Center for Bleeding Disorders, Seattle, WA

Disclosures: Wheeler: Octapharma: Honoraria, Research Funding; Bayer: Honoraria; Novo Nordisk: Consultancy, Honoraria; CSL Behring: Honoraria; Genentech: Honoraria; HEMA Biologics: Honoraria; Pfizer Inc: Honoraria; Sanofi-Aventis: Honoraria; Takeda Pharmaceuticals: Honoraria; UniQure: Honoraria; Vega Therapeutics, Inc.: Honoraria.

OffLabel Disclosure: I will discuss the use of hormonal contraception specifically for menstrual control, while the majority of these medications are only approved for contraception.

See more of: Hematologic Management of the Patient with Heavy Menstrual Bleeding
See more of: Education Program
Previous Presentation | Next Presentation >>